Comparer des méthodes

	Échelle de qualité de vie liée à la dégénérescence maculaire liée à l'âge	Questionnaire sur la fonction visuelle NEI-25 de l'Institut National de l'Oeil
Domaine	Ophtalmologie	Ophtalmologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2005	2001
Auteur d'origine	Mitchell J, Bradley C et al.	Mangione CM, Lee PP et al.
Type	Self-report	Self-report
Source fondatrice	Mitchell, J., Bradley, C., Anderson, S. J., et al. (2005). Perceived impact of retinal impairment on quality of life: the AMD and Cataract Symptom Effect Questionnaire. Health Qual Life Outcomes, 3(1), 12.	Mangione, C. M., Lee, P. P., Gutierrez, P. R., et al. (2001). Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol, 119(7), 1050-1058.
Alias	AMD-QoL, Macular QoL	VFQ-25
Apparentées	4	4
Résumé	The AMD Quality of Life (AMD-QoL) scale is a disease-specific instrument designed to measure the impact of age-related macular degeneration on patient-reported health-related quality of life. Developed by Mitchell, Bradley, and colleagues (2005), the AMD-QoL addresses concerns unique to macular disease: central vision loss, reading difficulty, facial recognition, driving impairment, and emotional burden. It serves as a primary or secondary outcome in AMD clinical trials and informs patient-centered care decisions.	The NEI-VFQ-25 is a 25-item self-report questionnaire measuring the impact of vision loss on health-related quality of life across multiple functional and psychological domains. Developed by the National Eye Institute (Mangione et al., 2001), it is the most widely used vision-specific QoL instrument in ophthalmology and serves as the gold standard for quantifying patient-reported visual disability across diverse eye conditions.